QG GENITO URINARY SYSTEM AND SEX HORMONES
QG04 UROLOGICALS
QG04C DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
QG04CB Testosterone-5-alpha reductase inhibitors
QG04CB51 finasteride and tadalafil
Last updated: 2024-01-17
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway
Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway
Tel: +47 21 07 81 60
E-mail:
Copyright/Disclaimer
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway
Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway
Tel: +47 21 07 81 60
E-mail:
Copyright/Disclaimer